Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

EGM Statement

11 Jan 2007 10:09

Mercury Group PLC11 January 2007 11 January 2007 Mercury Group plc ("Mercury" or the "Company") EGM Statement At the Extraordinary General Meeting of Mercury to be held at 10.00 a.m. thismorning the Chairman of the Company will make the following statement: "In the circular sent to shareholders on 15 December 2006, the SeniorIndependent Director stated that the board anticipated that the results for theyear ended 30 September 2006 would show material losses and that the Group wasperforming below expectations. I can report that trading of the Mercury Groupfor the first quarter of the current financial year was marginally ahead ofmanagement expectations due to a substantial one-off project being invoiced inlate December. The Directors of Mercury, in conjunction with their advisers, consideredcarefully the requirement for further equity capital before determining theamount to be sought from shareholders under the current placing and open offer.The directors consider that, in order to create shareholder value, furtherinvestment in the group's core business, Smith Melzack Pepper Angliss Limited("SMPA"), is necessary to enable it to grow to a critical mass. The funds beingraised from the placing and open offer will be used for the following purposes: - to pay overdue creditors of the Group; - to recruit additional personnel to increase income and improve management succession; - to invest and develop the SMPA infrastructure and brand name; - to provide an adequate headroom to satisfy AIM Rules; and - to pay the costs of the fund raising. I would like to reemphasise a statement made in the circular to shareholders,the essence of which is that should the proposals not be approved byshareholders, trading in the Company's shares will be suspended on AIM and theDirectors would have to seek financial advice from an insolvency practitionerregarding their obligations." For enquiries: Mercury Group plc 020 7393 4001Walter Goldsmith (non-executive chairman) John East & Partners Limited John East/David Worlidge 020 7628 2200 College Hill Associates 020 7457 2020Matthew Smallwood This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20213:27 pmRNSDirector/PDMR Shareholding
28th May 20212:43 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
11th May 20217:10 amRNSNon-Executive Director Change
11th May 20217:10 amRNSResults for the year ended 31 December 2020
20th Apr 20219:30 amRNSHolding(s) in Company
16th Apr 20219:47 amRNSHolding(s) in Company
29th Mar 202110:48 amRNSHolding(s) in Company
25th Mar 20218:05 amRNSCompletion of Acquisition & Director/PDMR Dealings
23rd Mar 20219:31 amRNSCorrection: Results of Fundraise and TVR
23rd Mar 20217:00 amRNSResults of Fundraise and Total Voting Rights
23rd Mar 20217:00 amRNSRe-release: Proposed acquisition of US-based RadMD
22nd Mar 20215:07 pmRNSProposed Fundraise to raise approximately £16m
22nd Mar 20215:07 pmRNSProposed acquisition of US-based RadMD
19th Mar 20217:00 amRNSMicrosoft Research’s Dr Junaid Bajwa joins as NED
22nd Feb 20217:00 amRNSMedica and Integral Diagnostics establish JV, MedX
11th Feb 202110:09 amRNSHolding(s) in Company
29th Jan 20219:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSAppointment of Liberum as Joint Corporate Broker
21st Jan 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSDr. Robert Lavis appointed Group Medical Director
4th Dec 202011:57 amRNSDirector/PDMR Shareholding
2nd Dec 20209:31 amRNSDirector/PDMR Shareholding
1st Dec 20209:34 amRNSHolding(s) in Company
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 202012:41 pmRNSHolding(s) in Company
10th Nov 20201:56 pmRNSHolding(s) in Company
6th Nov 20202:26 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSMedica acquires Global Diagnostics Ireland
27th Oct 20209:20 amRNSHolding(s) in Company
22nd Oct 20209:41 amRNSHolding(s) in Company
16th Oct 202011:26 amRNSHolding(s) in Company
7th Oct 202012:34 pmRNSHolding(s) in Company
16th Sep 20201:07 pmRNSDeclaration of Dividend
14th Sep 20207:00 amRNSInterim results demonstrate resilient performance
9th Sep 202010:36 amRNSHolding(s) in Company
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:56 amRNSHolding(s) in Company
21st Jul 202010:49 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading Update
11th Jun 20203:22 pmRNSDirector/PDMR Shareholding
1st Jun 20204:54 pmRNSIssue of Equity
28th May 202010:14 amRNSHolding(s) in Company
21st May 202012:55 pmRNSHolding(s) in Company
20th May 20204:25 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.